TrianglePUBLICATIONS · 3162515
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1988 Mar
- First author
- Capizzi RL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Capizzi RL
- type
- Author
- name
- Davis R
- type
- Author
- name
- Powell B
- type
- Author
- name
- Cuttner J
- type
- Author
- name
- Ellison RR
- type
- Author
- name
- Cooper MR
- type
- Author
- name
- Dillman R
- type
- Author
- name
- Major WB
- type
- Author
- name
- Dupre E
- type
- Author
- name
- McIntyre OR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Capizzi RL
- type
- Author
- name
- Davis R
- type
- Author
- name
- Powell B
- type
- Author
- name
- Cuttner J
- type
- Author
- name
- Ellison RR
- type
- Author
- name
- Cooper MR
- type
- Author
- name
- Dillman R
- type
- Author
- name
- Major WB
- type
- Author
- name
- Dupre E
- type
- Author
- name
- McIntyre OR
- type
- Author
- bibliography ids
- nci-bib-f3f5f302e7096e4b8ebcdf4f
- book metadata
- content sha256
- a8bb104e843e0d2f1f5c13c2710e454292a21d4c1eb9f0f88cc0911879053c71
- document type
- citation
- dois
- 10.1200/JCO.1988.6.3.499
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:3162515
- immutable id
- pubmed:3162515@a8bb104e843e0d2f1f5c13c2710e454292a21d4c1eb9f0f88cc0911879053c71
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 3
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 499-508
- volume
- 6
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 3162515
- provenance
- batch id
- a2059861e4099d0f54b4
- provider
- NCBI PubMed ESummary
- record sha256
- d894a01ba6001c5d3dd573dda8b6567855a113c2794f995b88bcbd2e12046ff4
- response sha256
- d338ccf62b1e9c7837730008fcd5c2d96e2453a423d7e449285b89d28e5a3bc3
- retrieved at
- 2026-09-09T23:45:12.786635+00:00
- publication date
- display
- 1988 Mar
- precision
- month
- year
- 1988
- publication types
- Clinical Trial
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/3162515/
- title
- Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study.
Preserved source evidence · Not medical advice